Clinical News: Page 3381

Cytogen 2002 loss grows despite revenue gains
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen reported 2002 revenue of $12.5 million, up 15% from the $10.9 million posted in 2001.
February 25, 2003
Acusphere launches phase III trials
By AuntMinnie.com staff writers
Ultrasound contrast agent developer Acusphere has begun a phase III clinical study of its AI-700 agent, which is designed for the detection of coronary artery disease in patients with ischemic heart disease.
February 25, 2003
Novoste modifies clinical trial
By AuntMinnie.com staff writers
Vascular brachytherapy firm Novoste has received Food and Drug Administration approval for an investigational device exemption supplement.
February 25, 2003
OmniSonics wins patent
By AuntMinnie.com staff writers
Vascular ultrasound developer OmniSonics Medical Technologies of Wilmington, MA, has received a U.S. patent for its ultrasonic tissue ablation device.
February 25, 2003
Physician groups navigate a rocky road to PET reimbursement
By Jonathan S. Batchelor
The Centers for Medicare and Medicaid Services (CMS) will update its policies for PET reimbursement next week. Ruth Tesar, executive director of Northern California PET Imaging in Sacramento, traces PET imaging's complicated reimbursement history.
February 25, 2003
Making mammography more precise
By Brian Casey
Letter from the Editor: Several companies are working on new technologies that could become useful adjuncts to mammography, increasing detection rates and boosting precision by ruling out masses that don’t need to be biopsied.
February 25, 2003
NAS shows sales uptick
By AuntMinnie.com staff writers
Radiopharmaceutical developer North American Scientific reported first-quarter sales of $5.1 million, up 4% from the $4.9 million posted in the first quarter of 2002.
February 24, 2003
Boston Scientific submits stent for PMA
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has submitted the first module of a premarket approval application for its Taxus paclitaxel-eluting coronary stent system to the Food and Drug Administration.
February 24, 2003
FDA clears Medis peripheral vascular software
By AuntMinnie.com staff writers
Medis Medical Imaging Systems has received Food and Drug Administration clearance for its QVA-CMS analytical software for use in quantitative analysis of vascular morphology in peripheral arteries.
February 24, 2003
New adjunctive breast techniques improve positive biopsy rates
By Deborah R. Dakins
LAS VEGAS - Nearly 80% of the 1.3 million breast biopsies performed in the U.S. each year to evaluate suspicious mammographic findings are benign, the FDA reports. But new adjunctive technologies in development could put a serious dent in that percentage, according to a presentation Monday at the National Consortium of Breast Centers.
February 24, 2003
Varian gets FDA OK for PaxScan
By AuntMinnie.com staff writers
Varian Medical Systems has received Food and Drug Administration 510(k) clearance for its PaxScan 4030 digital radiography system.
February 23, 2003
iCAD, Scanis ink licensing, supply deals
By AuntMinnie.com staff writers
Computer-aided detection firm Scanis of Foster City, CA, has signed a series of agreements with fellow CAD developer iCAD.
February 23, 2003
Previous Page
Page 3381 of 3659
Next Page